Terns PharmaceuticalsTERN

那斯達克 · USD
47.09
+2.48
(+5.56%)
收盤 12/12 04:59 (UTC+8)
盤後 
47.95 
+0.86 
(+1.83%)
12/12 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
27,71627,38327,42725,94924,93925,53725,446-33,18421,159
研發費用
19,91720,35318,72018,00415,16918,35218,58717,45914,83114,151
推銷及管理費用
7,7997,0308,7077,9459,7707,1856,8596,59918,3537,008
非經常性項目費用
----------
其他營業費用
----------
營業利益
-27,716
-27,383
-27,427
-25,949
-24,939
-25,537
-25,446
-24,058
-33,184
-21,159
其他收入及費用
3,1273,3543,6074,1903,0562,8623,1703,0883,4753,335
利息費用
----------
稅前純益
-24,589
-24,029
-23,820
-21,759
-21,883
-22,675
-22,276
-20,970
-29,709
-17,824
所得稅
46648840626197495872
稅後純益
-24,635
-24,093
-23,908
-21,799
-21,945
-22,736
-22,373
-21,019
-29,767
-17,896
基本每股稅後盈餘(元)
-0.27-0.26-0.26-0.24-0.28-0.31-0.30--0.42-0.25
稀釋每股稅後盈餘(元)
-0.27-0.26-0.26-0.23-0.28-0.31-0.30-0.29-0.42-0.25
基本平均股數(千股)
91701.0091575.0091473.0091240.0077819.0074459.0074399.00-71530.0071364.00
稀釋平均股數(千股)
91701.0091575.0091473.0091240.0077819.0074459.0074399.00-71530.0071364.00
還原基本每股稅後盈餘(元)
-0.27-0.26-0.26-0.24-0.28-0.31-0.30--0.42-0.25
還原稀釋每股稅後盈餘(元)
-0.27-0.26-0.26-0.23-0.28-0.31-0.30-0.29-0.42-0.25
還原基本平均股數(千股)
91,70191,57591,47391,24077,81974,45974,399-71,53071,364
還原稀釋平均股數(千股)
91,70191,57591,47391,24077,81974,45974,399-71,53071,364
EBITDA(千元)
-24,467-23,947-23,760-21,745-21,681-22,445-22,400-22,249-31,236-18,582

大家都在看

HOT